Supplier · Peer benchmark
Peer comparison
How Cambridge Drug Discovery stacks up against suppliers competing for the same workloads — based on overlap with its 1 signature CPV code over the last 24 months.
Value band:
/
CohortCambridge Drug Discovery(You)Mace Consult LimitedMace LimitedLGC LimitedSSCLNewton Europe Limited
iAuto-picked from 1 signature CPV code · last 24 months overlap
Metric | MC Mace Consult Limited Peer · rank #1 | MA Mace Limited Peer · rank #2 | LG LGC Limited Peer · rank #3 | CD Cambridge Drug Discovery (You) · target supplier | SS SSCL Peer · rank #5 | NE Newton Europe Limited Peer · rank #6 |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | £70.7m | £762k | £646k | — | — | — |
| Framework headroomPer-supplier share of framework ceilings | £2.6m | £53k | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £738.3m | £5.2bn | £560.1m | £30k(−100%) | £159.4m | £97.3m |
| Contracts won (12m)Distinct awards last year | 15 | 9 | 3 | — | — | |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —